To schedule a new patient appointment call 844-CANCERNJ (844-226-2376)
To schedule a follow-up appointment call 732-235-7615
For all other inquiries call 732-235-2465.
My first understanding of treating the “whole” patient and not just the disease came early in my career. As a first-year medical student, I took part in a program that paired me with an elderly South Asian female patient with gynecologic cancer. My experiences with her visits for treatments and doctor’s appointments, hospitalizations and eventually her death, made a lasting impression on my development as a physician. From that time, I knew that good communication between doctor and patient was a critical aspect in providing comprehensive care.
I joined The Cancer Institute of New Jersey originally in 2008 as an assistant professor of medicine with a focus on thoracic oncology and hematologic malignancies following a fellowship in hematology/oncology at UMDNJ-Robert Wood Johnson Medical School. I trained in internal medicine with a focus on research and skill development in palliative care.
In 2011, I became the medical director at the Cancer Institute of New Jersey’s program at RWJ Hamilton, where I was responsible for developing and maintaining a patient-centered cancer treatment, prevention and screening program tailored toward both patient and family. I left Rutgers Cancer Institute in 2015 to join Summit Medical Group as the Division Chief of Medical Oncology and Hematology where I guided the expansion of the cancer program as well as cancer research program. After being away from academic medicine for a few years and missing that culture, I rejoined Rutgers Cancer Institute of New Jersey’s Genitourinary Oncology Program in 2018.
Looking to continually improve my physician-patient relationship skills I have completed training through Oncotalk, now VitalTalk, an NCI sponsored research study and also completed Oncotalk Teach, a faculty development program. Knowing that today’s physician training is key to how patient care is delivered and communicated in the future, I have contributed to the Oncotalk Teach program. Sharpened communication skills continue to allow me to care for my terminally ill patients with compassion and patience.
I am board certified in palliative care and continue to teach the principles of palliative care to medical students, residents, fellows and practicing physicians. I started palliative care rotations for medical students at RWJMS, an annual Palliative Care Symposium for the Department of Medicine and a teaching program for residents.
I continue to be amazed by the teaching my patients give me each and every day by “living with cancer.” They have taught me that the most important things in life are the people I am surrounded by every day - my family, my colleagues and my patients. It is my continuing goal to remain abreast of the latest treatments, technologies and communication aspects, so that I can provide the best care to the Central Jersey community. As part of that commitment, I also work with closely with basic research scientists and clinical researchers at Rutgers Cancer Institute to develop new therapies for genitourinary cancers.
Prostate cancer, kidney cancer, testicular cancer, bladder cancer, and palliative care
July 31, 2024
Dr. Saraiya is the only person I trust with my Cancer.
June 27, 2024
Excellent service
March 26, 2024
Dr. Saraiya is superior.
February 20, 2024
Showed genuine concern about my well being and state of mind.
January 18, 2024
Dr. Saraiya is the best! He always listens to my concerns and always shows concern for my issues. He's a wonderful physician.
January 16, 2024
Thank you Dr. Saraiya for everything you do. I appreciate you very much.
January 16, 2024
I requested him for my oncologist.
Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with your insurance company they are still a participating plan prior to receiving services or care. Each plan is different and some provide different levels of coverage that could make a difference in your out-of-pocket costs. It is always best for the patient receiving care to contact their insurance company to obtain more information.
Dr. Biren Saraiya discusses advances in prostate cancer with EBC Radio.
With recent changes in recommendations for PSA testing for prostate cancer, confusion may exist for those considering the screening. Dr. Saraiya shares information on the topic. Learn more.
ASCO and other national organizations have issued guidelines on integrating palliative and supportive care into standard oncology practice, but evidence suggests that patient needs are often not met, especially for those with genitourinary cancers. Read more.